Invention Grant
- Patent Title: Compounds
- Patent Title (中): 化合物
-
Application No.: US14404188Application Date: 2013-05-30
-
Publication No.: US09303030B2Publication Date: 2016-04-05
- Inventor: Patrick René Angibaud , Isabelle Noëlle Constance Pilatte , Olivier Alexis Georges Querolle
- Applicant: ASTEX THERAPEUTICS LIMITED
- Applicant Address: GB Cambridge
- Assignee: ASTEX THERAPEUTICS LIMITED
- Current Assignee: ASTEX THERAPEUTICS LIMITED
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1209609.5 20120530
- International Application: PCT/GB2013/051428 WO 20130530
- International Announcement: WO2013/179034 WO 20131205
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D403/04 ; A61K31/4375 ; A61K31/5025 ; A61K31/5377 ; A61K45/06
Abstract:
The invention relates to new pyridopyrazine and naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20150239883A1 NEW COMPOUNDS Public/Granted day:2015-08-27
Information query
